Mycophenolate mofetil treatment of crescentic Henoch-Schönlein nephritis with IgA depositions

Mycophenolate mofetil (MMF) is considered to be a promising therapeutic agent in primary glomerulonephritis but there are no data on the use of MMF in Henoch-Schönlein nephritis (HSN). Herein we report the first adult crescentic HSN patient in whom long-term complete remission was achieved after MMF...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Scandinavian journal of urology and nephrology 2008, Vol.42 (2), p.178-180
Hauptverfasser:	Dede, Fatih, Onec, Birgul, Ayli, Deniz, Isik Gonul, Ipek, Onec, Kursad
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Biological and medical sciences Biopsy Dermatology Disease Progression Dose-Response Relationship, Drug Female Follow-Up Studies Glomerulonephritis Glomerulonephritis, IGA - drug therapy Glomerulonephritis, IGA - etiology Glomerulonephritis, IGA - pathology Humans Immunosuppressive Agents - therapeutic use Kidney - pathology Medical sciences Mycophenolic Acid - analogs & derivatives Mycophenolic Acid - therapeutic use Nephrology. Urinary tract diseases Nephropathies. Renovascular diseases. Renal failure Prodrugs Purpura, Schoenlein-Henoch - complications Purpura, Schoenlein-Henoch - drug therapy Purpura, Schoenlein-Henoch - pathology Remission Induction - methods Vascular disorders of the skin
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Mycophenolate mofetil (MMF) is considered to be a promising therapeutic agent in primary glomerulonephritis but there are no data on the use of MMF in Henoch-Schönlein nephritis (HSN). Herein we report the first adult crescentic HSN patient in whom long-term complete remission was achieved after MMF therapy.
ISSN:	0036-5599 1651-2065
DOI:	10.1080/00365590701571514